Cargando…

Development of an ELISA-Based Potency Assay for Inactivated Influenza Vaccines Using Cross-Reactive Nanobodies

Inactivated vaccines are the main influenza vaccines used today; these are usually presented as split (detergent-disrupted) or subunit vaccines, while whole-virus-inactivated influenza vaccines are rare. The single radial immune diffusion (SRD) assay has been used as the gold standard potency assay...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheung, Chung Y., Dubey, Sitara, Hadrovic, Martina, Ball, Christina R., Ramage, Walter, McDonald, Jacqueline U., Harvey, Ruth, Hufton, Simon E., Engelhardt, Othmar G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503116/ https://www.ncbi.nlm.nih.gov/pubmed/36146550 http://dx.doi.org/10.3390/vaccines10091473

Ejemplares similares

Nanobodies mapped to cross-reactive and divergent epitopes on A(H7N9) influenza hemagglutinin using yeast display
por: Gaiotto, Tiziano, et al.
Publicado: (2021)

Broad Reactivity Single Domain Antibodies against Influenza Virus and Their Applications to Vaccine Potency Testing and Immunotherapy
por: Tung Yep, Andrew, et al.
Publicado: (2021)

Cross-Reactive and Lineage-Specific Single Domain Antibodies against Influenza B Hemagglutinin
por: Ramage, Walter, et al.
Publicado: (2019)

Potency determination of inactivated H7 influenza vaccines using monoclonal antibody‐based ELISA and biolayer interferometry assays
por: Vasudevan, Anupama, et al.
Publicado: (2017)

Protection From Influenza by Intramuscular Gene Vector Delivery of a Broadly Neutralizing Nanobody Does Not Depend on Antibody Dependent Cellular Cytotoxicity
por: Del Rosario, Joanne Marie M., et al.
Publicado: (2020)

The Breadth of Cross Sub-Type Neutralisation Activity of a Single Domain Antibody to Influenza Hemagglutinin Can Be Increased by Antibody Valency
por: Hufton, Simon E., et al.
Publicado: (2014)

Assessment of in vitro potency of inactivated Newcastle disease oil-adjuvanted vaccines using hemagglutination test and blocking ELISA
por: Aly, Saleh E., et al.
Publicado: (2018)

An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines
por: Bodle, Jesse, et al.
Publicado: (2023)

The Generation of a Nanobody-Based ELISA for Human Microsomal Epoxide Hydrolase
por: He, Qiyi, et al.
Publicado: (2023)

An ELISA Assay for Quantifying Monomeric C-Reactive Protein in Plasma
por: Zhang, Lin, et al.
Publicado: (2018)

Cross-Neutralising Nanobodies Bind to a Conserved Pocket in the Hemagglutinin Stem Region Identified Using Yeast Display and Deep Mutational Scanning
por: Gaiotto, Tiziano, et al.
Publicado: (2016)

Nanobody-Based Indirect Competitive ELISA for Sensitive Detection of 19-Nortestosterone in Animal Urine
por: Yang, Yuan-yuan, et al.
Publicado: (2021)

Hemagglutinin Quantitative ELISA-based Potency Assay for Trivalent Seasonal Influenza Vaccine Using Group-Specific Universal Monoclonal Antibodies
por: Chae, Wonil, et al.
Publicado: (2019)

Determination of Aspergillus pathogens in agricultural products by a specific nanobody-polyclonal antibody sandwich ELISA
por: Wang, Ting, et al.
Publicado: (2017)

HRP-conjugated-nanobody-based cELISA for rapid and sensitive clinical detection of ASFV antibodies
por: Zhao, Huijun, et al.
Publicado: (2022)

Quantification of soluble epoxide hydrolase inhibitors in experimental and clinical samples using the nanobody-based ELISA
por: Yang, Huiyi, et al.
Publicado: (2023)

A multispecies competitive nanobody-based ELISA for the detection of antibodies against hepatitis E virus
por: Arce, Lorena Paola, et al.
Publicado: (2023)

Meeting report and review: Immunological assays and correlates of protection for next‐generation influenza vaccines
por: Krammer, Florian, et al.
Publicado: (2019)

Evaluation of Oxytetracycline Metabolites Cross-Reactivity with Oxytetracycline Enzyme-Linked Immunosorbent Assay (ELISA)
por: Hijaz, Faraj, et al.
Publicado: (2020)

The Ability of a Non-Egg Adapted (Cell-Like) A(H1N1)pdm09 Virus to Egg-Adapt at HA Loci Other than 222 and 223 and Its Effect on the Yield of Viral Protein
por: Nicolson, Carolyn, et al.
Publicado: (2016)

Assaying the Potency of Influenza Vaccines
por: Minor, Philip D.
Publicado: (2015)

The use of nanobodies in a sensitive ELISA test for SARS-CoV-2 Spike 1 protein
por: Girt, Georgina C., et al.
Publicado: (2021)

A simple nanobody-based competitive ELISA to detect antibodies against African swine fever virus
por: Zhao, Jiakai, et al.
Publicado: (2022)

Framework humanization optimizes potency of anti-CD72 nanobody CAR-T cells for B-cell malignancies
por: Temple, William C, et al.
Publicado: (2023)

Establishment of the first WHO International Standard for antiserum to Respiratory Syncytial Virus: Report of an international collaborative study
por: McDonald, Jacqueline U., et al.
Publicado: (2018)

Development of nanobody-horseradish peroxidase-based sandwich ELISA to detect Salmonella Enteritidis in milk and in vivo colonization in chicken
por: Gu, Kui, et al.
Publicado: (2022)

zGrad is a nanobody-based degron system that inactivates proteins in zebrafish
por: Yamaguchi, Naoya, et al.
Publicado: (2019)

Development of an Anti-Zika and Anti-Dengue IgM ELISA Assay: Evaluation of Cross Reactivity and Validation
por: Cerutti, Helena, et al.
Publicado: (2022)

The ELISA Detectability and Potency of Pegfilgrastim Decrease in Physiological Conditions: Key Roles for Aggregation and Individual Variability
por: Xie, Tao, et al.
Publicado: (2020)

A novel biotinylated nanobody-based blocking ELISA for the rapid and sensitive clinical detection of porcine epidemic diarrhea virus
por: Ma, Zhiqian, et al.
Publicado: (2019)

Highly Sensitive Detection of Zika Virus Nonstructural Protein 1 in Serum Samples by a Two-Site Nanobody ELISA
por: Delfin-Riela, Triana, et al.
Publicado: (2020)

Nanobody-Based Blocking of Binding ELISA for the Detection of Anti-NS1 Zika-Virus-Specific Antibodies in Convalescent Patients
por: Delfin-Riela, Triana, et al.
Publicado: (2023)

A high-affinity RBD-targeting nanobody improves fusion partner’s potency against SARS-CoV-2
por: Yao, Hebang, et al.
Publicado: (2021)

Bananas decrease acetaminophen potency in in vitro assays
por: Uesawa, Yoshihiro, et al.
Publicado: (2018)

Recombinant expression of nanobodies and nanobody-derived immunoreagents
por: de Marco, Ario
Publicado: (2020)

The Development and Validation of a Novel Nanobody-Based Competitive ELISA for the Detection of Foot and Mouth Disease 3ABC Antibodies in Cattle
por: Gelkop, Sigal, et al.
Publicado: (2018)

Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions
por: Schriek, Angela I., et al.
Publicado: (2022)

THE ANTIGENIC POTENCY OF EPIDEMIC INFLUENZA VIRUS FOLLOWING INACTIVATION BY ULTRAVIOLET RADIATION
por: Salk, Jonas E., et al.
Publicado: (1940)

Design and optimization of an IgG human ELISA assay reactive to recombinant RBD SARS-CoV-2 protein
por: Rodríguez, María Celeste, et al.
Publicado: (2022)

Determination of Cutoff of ELISA and Immunofluorescence Assay for Scrub Typhus
por: Gupta, Nitin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mltj45aoli79g270c0clf9djkt